German Renewable Energy Stock News

XTRA:AFX
XTRA:AFXMedical Equipment

Does ESCRS Cataract Launches Change The Bull Case For Carl Zeiss Meditec (XTRA:AFX)?

Carl Zeiss Meditec used the 2026 ESCRS congress to showcase new cataract and laser vision products, including the AT LUCIA toric 721P intraocular lens, an EVA NEXUS cataract-only surgical configuration, and a ZEISS Surgery Planner cloud tool for digitally connected cataract workflows. The focus on a bitoric hydrophobic monofocal IOL with a non-constant asphericity profile and tightly integrated digital planning highlights management’s push to deepen its premium cataract offering and embed...
XTRA:SHL
XTRA:SHLMedical Equipment

Siemens Healthineers (XTRA:SHL) Eyes MRI Growth, Is The Stock Still Cheap?

MarketsandMarkets now expects the global MRI systems market to expand, and Siemens Healthineers (XTRA:SHL) sits directly in that conversation as it spends heavily on helium-free and AI-assisted scanners. Siemens Healthineers’ share price tells a mixed story, with the stock down 13.39% on a year to date basis and the 1-year total shareholder return declining 17.79%, even as a 10.40% 90-day share price gain suggests some momentum is starting to rebuild around its MRI and broader imaging...
XTRA:SB1
XTRA:SB1Interactive Media and Services

Smartbroker Holding (XTRA:SB1) Stock Sees Revenue Strength But Profit Questions Persist

Smartbroker Holding heads into this earnings story with a bruised chart, down almost 30% over three months, yet the latest half-year tells a more nuanced tale. H1 2026 revenue came in at €35.749 million while the group still reported a net loss of €2.949 million. The key tension is simple. The business is putting up solid turnover for an online brokerage platform, but the path from high growth forecasts to actual profitability remains the headline question for anyone watching the stock at...
XTRA:M12
XTRA:M12Healthcare

Can M1 Kliniken (XTRA:M12) Stock Justify Its Premium P/E After Profit Slip?

M1 Kliniken walked into this earnings season with a reputation for steady profit expansion and a premium P/E tag to match. The share price barely flinched this week despite that narrative, even as the fresh half year numbers pointed to a clear pressure point. Net income and basic earnings per share for H1 2026 landed below the levels reported in both halves of 2025. For a stock that trades on a higher multiple than healthcare peers and carries a dividend flagged as not well covered, that...
XTRA:FRE
XTRA:FREHealthcare

What Fresenius Shares Generic Drug Launch Means For Shareholders

Fresenius Kabi, part of Fresenius SE KGaA, has launched an FDA approved generic Sugammadex Injection in the U.S. in a 200 mg per 2 mL Simplist prefilled syringe, filled and packaged domestically and indicated for reversal of certain neuromuscular blockade in adults and children from 2 years. The move extends Fresenius Kabi’s Simplist prefilled syringe range directly into operating rooms, which could influence procedure workflows, medication error rates, and the cost profile of anesthesia...
XTRA:2GB
XTRA:2GBElectrical

3 European Energy Stocks Retail Investors Are Watching Before Winter Power Costs Rise

Energy has moved from background cost to front-page risk, with Iran–US conflict, tight European gas supplies and winter approaching all at once. That pressure is painful for many industrials, yet it also shines a light on companies tied to efficiency, on-site renewables and smarter energy use. This article walks through three European stocks exposed to that news backdrop, explaining why some investors are watching them closely right now. The three stocks profiled below are a sample set, and...
XTRA:DBAN
XTRA:DBANCapital Markets

European Growth Stocks With High Insider Ownership For September 2026

As European markets navigate the complexities of rising energy prices and inflation concerns, growth stocks with high insider ownership are capturing attention due to their potential resilience in uncertain times. In this environment, companies where insiders hold significant stakes may offer a unique alignment of interests between management and shareholders, potentially enhancing long-term value creation.
XTRA:DTE
XTRA:DTETelecom

Deutsche Telekom (XTRA:DTE) Revamps Its Leadership Team, Is The Valuation Gap Still Justified?

Deutsche Telekom (XTRA:DTE) just reshaped its leadership bench, with new appointments in product, technology and finance that sharpen investor focus on how fresh decision makers could influence the group’s long term direction. Recent trading has been quieter than the headline changes suggest, with Deutsche Telekom’s share price near €27.88 and short term moves slightly weaker, while a three year total shareholder return of 48.04% and five year total shareholder return of 88.46% point to...
XTRA:SAP
XTRA:SAPSoftware

Is SAP (XTRA:SAP) Undervalued Following New Customer Experience Partnership Wins?

Recent client announcements around SAP (XTRA:SAP) focus on customer experience. Trifork Group and N4XT are expanding partnerships that put SAP Customer Experience and SAP Sales Cloud v2 at the center of new deployment projects. SAP’s recent client wins come after a choppy share price run. The stock is down 2.76% on the day and shows a 7-day share price return of 4.18% in the red, but a much stronger 90-day share price return of 26.78%. The 3-year total shareholder return of 45.04% contrasts...
XTRA:AG1
XTRA:AG1Specialty Retail

AUTO1 Group (XTRA:AG1) Faces A CFO Exit, Is It Still Below Fair Value?

AUTO1 Group (XTRA:AG1) is in focus after CFO Christian Wallentin resigned for family reasons. CEO Christian Bertermann will temporarily assume finance duties as investors weigh this leadership shift against the firm’s latest half-year earnings. The AUTO1 Group share price closed at €20.20, with a 1-day share price gain of 1.20% after the CFO news. However, the 7-day share price return is down 8.10% and the year-to-date share price performance has declined 28.11%. The 3-year total shareholder...
XTRA:KSB
XTRA:KSBMachinery

European Equities Trading Below Estimated Value In September 2026

In September 2026, European equities experienced a challenging period as rising energy prices and geopolitical tensions weighed on investor sentiment, with the pan-European STOXX Europe 600 Index ending the week down. Despite these pressures, opportunities may exist in stocks trading below their estimated value, offering potential for growth as market conditions stabilize and rate concerns moderate.
DB:M0LY
DB:M0LYMetals and Mining

Greenland Resources And 2 Other European Penny Stocks Worth Your Attention

European markets have recently faced pressures from rising energy prices and inflation concerns, although sentiment has stabilized somewhat as these factors moderated. In such a climate, investors often seek opportunities in areas of the market that may not be immediately obvious. Penny stocks, while an older term, continue to represent intriguing prospects for those looking at smaller or newer companies with strong financials and growth potential.
XTRA:VOW3
XTRA:VOW3Auto

What Is Volkswagen (XTRA:VOW3) Signaling With Its Latest Restructuring Moves?

Volkswagen (XTRA:VOW3) is weighing a potential sale of its Ducati motorcycle unit as part of a wider restructuring push. The group has agreed to sell its Osnabrück plant, which is set to be converted for defence and security production. An Israeli defence company is expected to partner on the repurposed facility, marking a shift in how the former Volkswagen site will be used. These moves highlight how large manufacturers are rethinking portfolios and asset footprints. This can matter if you...
XTRA:EDL
XTRA:EDLEntertainment

3 Global Dividend Stocks Yielding Up To 7.7%

As global markets navigate through geopolitical tensions, rising oil prices, and shifting monetary policy expectations, investors are keenly focused on strategies that can provide stability and income. In this context, dividend stocks have become an attractive option for those looking to balance growth with regular income streams amidst market volatility.
XTRA:RWE
XTRA:RWERenewable Energy

How Renewable Power Deal Will Impact RWE Stock Investors

RWE has agreed a long-term power purchase deal to supply up to 75 GWh of renewable electricity each year to Air Products’ hydrogen facilities, including a new liquefaction plant in Rotterdam that is planned to be Europe’s largest liquid hydrogen site and to comply with EU RED III rules. The contract links RWE’s renewable generation directly to hydrogen production that qualifies as renewable fuel of non-biological origin, which can sharpen demand visibility for its clean power while tying the...
XTRA:ADS
XTRA:ADSLuxury

adidas (XTRA:ADS) Has The Market Watching, What Is Behind The Attention?

Adidas (XTRA:ADS) is back under scrutiny after a local Single Shoe advertising campaign featuring former Israeli soldier Shalev Biton drew criticism, sparked boycott calls, and prompted apologies from Adidas units in Israel and Arabia. At a share price of €146.45, adidas has seen the 1 month share price return fall 12.49% and the 3 month share price return decline 15.49%, while the 1 year total shareholder return is down 16.35%. This suggests recent sentiment has weakened even as headlines...
XTRA:DWS
XTRA:DWSCapital Markets

Is DWS Group GmbH KGaA (XTRA:DWS) Fully Priced On Its Deutsche Asset Management Rebrand?

DWS Group GmbH KGaA (XTRA:DWS) has set a clear marker for its future identity. The asset manager plans to rebrand globally as Deutsche Asset Management from November 2026, unifying operations under one banner. DWS Group GmbH KGaA shares trade at €77.1, with a 7 day share price return of 3.35% and a 90 day gain of 33.28%. This lines up with a strong 1 year total shareholder return of 56.59%, suggesting momentum has been building as the rebrand story has taken shape. Compare the rebrand-driven...
XTRA:SAP
XTRA:SAPSoftware

SAP (XTRA:SAP) Puts AI At The Center Of Its Business Software

SAP (XTRA:SAP) is shifting its company-wide focus to AI-driven business solutions, centered on a newly announced enterprise AI platform. The CEO outlined plans for the platform to reshape how customers run core processes, tying AI directly into SAP's business applications. SAP's board has set an urgent timetable for a significant AI breakthrough within months, citing rising competitive pressure from other software leaders. The AI push marks a material change in SAP's direction that could...
HMSE:BIO0
HMSE:BIO0Biotechs

Biotest GmbH KGaA (HMSE:BIO0) After Trimodulin Buzz Faces A Split Valuation View

Biotest GmbH KGaA (HMSE:BIO0) is back in focus after fresh industry commentary highlighted its Trimodulin candidate among emerging therapies in community-acquired bacterial pneumonia, drawing attention to the company’s role in this specific treatment niche. Set against the Trimodulin headlines, Biotest GmbH KGaA’s share price sits at €33.2 with a 90‑day share price return of 3.11% and year to date gain of 5.06%, while the 12.30% total shareholder return over one year points to gradually...
XTRA:DB1
XTRA:DB1Capital Markets

What Deutsche Börse Shares Fixed Income Offering Means For Shareholders

Deutsche Börse AG has completed a €600 million fixed to floating rate senior, subordinated, unsecured bond offering, with callable variable coupon notes maturing in September 2052. The 26 year fixed income deal extends Deutsche Börse’s funding profile and adds long dated, flexible interest cost to support its market infrastructure and data ambitions. With this €600 million fixed income issuance now in place, we can assess how the new long dated funding shapes Deutsche Börse's investment...
XTRA:BAYN
XTRA:BAYNPharmaceuticals

How Positive Phase III Imaging Data Will Impact Bayer Stock Investors

Bayer reported detailed Phase III REVEAL data for its investigational PET radiotracer iodine 124 evuzamitide in cardiac amyloidosis, showing high sensitivity and specificity across AL and ATTR subtypes and a generally manageable safety profile in 170 evaluated adults. The compound already holds Breakthrough Therapy and Orphan Drug designations, so positive diagnostic accuracy data could strengthen Bayer’s late stage pipeline story in specialized cardiovascular imaging. We will now look at...
XTRA:LXS
XTRA:LXSChemicals

Is LANXESS (XTRA:LXS) Undervalued As Vulkanox 4060 Nears Commercial Production?

LANXESS (XTRA:LXS) has put its new tire additive Vulkanox 4060 in the spotlight after securing EU REACH registration. The company is positioning the compound as an environmentally oriented alternative to 6PPD for European producers. LANXESS shares trade at €15.46, with a 1-day share price return of 1.05% and a 7-day share price return of 2.86%, yet the year-to-date share price return is down 11.76% and the 1-year total shareholder return has declined 33.38%, pointing to fading long-term...
XTRA:IFX
XTRA:IFXSemiconductor

Is Infineon Technologies (XTRA:IFX) Stock Priced Right After An 85% Run?

Infineon Technologies has delivered an 85.0% return over the past three years, yet current checks suggest the stock now trades close to what a Discounted Cash Flow (DCF) based intrinsic value estimate would call fair rather than clearly cheap. The 85.0% gain over three years leaves existing holders sitting on strong headline returns, which raises the bar for fresh buyers looking for value. Infineon Technologies features as a key supplier in the growing avalanche breakdown diodes market that...
XTRA:DBK
XTRA:DBKCapital Markets

Deutsche Bank (XTRA:DBK) Could Be 10% Above Fair Value As Inflation Risks Return

Deutsche Bank’s inflation warning as a fresh equity signal Deutsche Bank (XTRA:DBK) has put inflation risk back on the table. In its latest dislocations report, the lender argues that comfort around prices, rates and growth now rests on fragile assumptions. The report points to a squeeze from rising energy, food and commodity costs just as investors are pricing in steady conditions across bonds, equities and credit. That situation is the starting point for reassessing Deutsche Bank...